Drug Description in Trials / DrugBank / KEGG DRUG /


Search results


No. 薬物名(臨床試験情報から抽出) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
118F-AV-1451----3件: 5, 7, 127
218F-FDG1件: Fludeoxyglucose (18F)---8件: 5, 6, 7, 13, 84, 85, 127, 300
318F-RO6958948----3件: 5, 7, 127
4ABBV-8E12----2件: 5, 7
5AL----11件: 5, 6, 7, 13, 28, 51, 67, 86, 97, 114, 127
6Anti-Parkinson medication----5件: 5, 6, 7, 8, 17
7Apomorphine1件: Apomorphine1件: D07460 2件: DRD1,
DRD2 💬
11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬3件: 5, 6, 7
8BIIB092----3件: 5, 7, 127
9BOTULINUM TOXIN TYPE A1件: Botulinum toxin type A1件: D00783 1件: SNAP25 💬2件: Insulin secretion, Synaptic vesicle cycle 💬10件: 2, 5, 6, 7, 13, 15, 17, 70, 113, 149
10Davunetide1件: Davunetide1件: D09401 --3件: 5, 7, 127
11Davunetide (AL-108, NAP)1件: Davunetide1件: D09401 --3件: 5, 7, 127
12Dopamine1件: Dopamine1件: D07870 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬3件: 6, 7, 74
13Fasudil1件: Fasudil1件: D07941 2件: ROCK1,
ROCK2 💬
23件: Axon guidance, Chemokine signaling pathway, Focal adhesion, Human cytomegalovirus infection, Leukocyte transendothelial migration, Lipid and atherosclerosis, MicroRNAs in cancer, Oxytocin signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Platelet activation, Proteoglycans in cancer, Regulation of actin cytoskeleton, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, TGF-beta signaling pathway, Tight junction, Vascular smooth muscle contraction, Wnt signaling pathway, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway 💬4件: 2, 5, 7, 51
14Flortaucipir1件: Flortaucipir1件: D11210 1件: MAPT 💬4件: Alzheimer disease, MAPK signaling pathway, Parkinson disease, Pathways of neurodegeneration - multiple diseases 💬3件: 5, 7, 127
15Flortaucipir F181件: Flortaucipir1件: D11210 1件: MAPT 💬4件: Alzheimer disease, MAPK signaling pathway, Parkinson disease, Pathways of neurodegeneration - multiple diseases 💬3件: 5, 7, 127
16Flutemetamol1件: Flutemetamol (18F)---4件: 5, 6, 7, 127
17Lithium1件: Lithium citrate1件: D04749 --5件: 2, 5, 6, 7, 8
18NT 101----4件: 5, 6, 7, 17
19Raclopride1件: Raclopride---4件: 5, 6, 7, 17
20TPI 287----2件: 5, 7
21TPI 287 2 mg/m2----2件: 5, 7
22TPI-2871件: TPI-287---2件: 5, 7
23TPI-287 20 mg/m21件: TPI-287---2件: 5, 7
24TPI-287 6.3 mg/m21件: TPI-287---2件: 5, 7
25Vizamyl1件: Flutemetamol (18F)---3件: 5, 7, 127
26Vizamyl (flutemetamol(F-18))1件: Flutemetamol (18F)---3件: 5, 7, 127
27Xeomin1件: Botulinum toxin type A1件: D00783 1件: SNAP25 💬2件: Insulin secretion, Synaptic vesicle cycle 💬7件: 5, 6, 7, 13, 15, 17, 113